Fonar Corporation - Common Stock (FONR)
19.09
+0.00 (0.00%)
NASDAQ· Last Trade: Sep 12th, 8:32 AM EDT
Detailed Quote
| Previous Close | 19.09 |
|---|---|
| Open | - |
| Bid | 19.02 |
| Ask | 19.15 |
| Day's Range | N/A - N/A |
| 52 Week Range | 13.90 - 19.11 |
| Volume | 0 |
| Market Cap | 121.36M |
| PE Ratio (TTM) | 34.71 |
| EPS (TTM) | 0.6 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | - |
Chart
About Fonar Corporation - Common Stock (FONR)
Fonar Corp is a medical technology company primarily focused on the development and manufacturing of magnetic resonance imaging (MRI) systems. The company is known for its innovative approach to MRI technology, including the design of advanced imaging equipment that aims to improve diagnostic capabilities for various medical conditions. Fonar also engages in research and development activities to enhance its product offerings and expand its market presence. Through its commitment to advancing imaging solutions, the company plays a critical role in the healthcare industry by providing healthcare professionals with crucial tools for patient diagnosis and treatment planning. Read More
News & Press Releases
Net Income decreased 25% to $2.3 million for the quarter ended March 31, 2026 as compared to the quarter ended...
Via Newsfile · May 11, 2026
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
By Halper Sadeh LLC · Via GlobeNewswire · April 28, 2026
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of FONAR Corporation (NasdaqCM: FONR) to affiliates of Chief Executive Officer Timothy Damadian and certain executives and directors of the company. Under the terms of the proposed transaction, shareholders of FONAR will receive $19.00 per share of the Company's common stock, $19.00 per share of the Company’s Class B common stock, $6.34 per share of the Company’s Class C common stock. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
By Kahn Swick & Foti, LLC · Via Business Wire · April 20, 2026
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
By Halper Sadeh LLC · Via GlobeNewswire · April 15, 2026
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
By Halper Sadeh LLC · Via GlobeNewswire · March 31, 2026
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
By Halper Sadeh LLC · Via GlobeNewswire · March 20, 2026
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
By Halper Sadeh LLC · Via GlobeNewswire · March 17, 2026
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
By Halper Sadeh LLC · Via GlobeNewswire · March 12, 2026
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
By Halper Sadeh LLC · Via GlobeNewswire · March 4, 2026
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
By Halper Sadeh LLC · Via GlobeNewswire · March 4, 2026
Cash and cash equivalents decreased 6% to $53.0 million at December 31, 2025, as compared to $56.3 million for the...
Via Newsfile · February 13, 2026
Shareholders should contact the firm as there may be limited time to enforce your rights.
By Halper Sadeh LLC · Via GlobeNewswire · February 2, 2026
BALA CYNWYD, Pa., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · February 2, 2026
Shareholders should contact the firm as there may be limited time to enforce your rights
By Halper Sadeh LLC · Via GlobeNewswire · January 23, 2026
BALA CYNWYD, Pa., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · January 20, 2026
Shareholders should contact the firm as there may be limited time to enforce your rights
By Halper Sadeh LLC · Via GlobeNewswire · January 17, 2026
BALA CYNWYD, Pa., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · January 12, 2026
Shareholders should contact the firm as there may be limited time to enforce your rights
By Halper Sadeh LLC · Via GlobeNewswire · January 8, 2026
Shareholders should contact the firm as there may be limited time to enforce your rights
By Halper Sadeh LLC · Via GlobeNewswire · January 6, 2026
Shareholders should contact the firm as there may be limited time to enforce your rights.
By Halper Sadeh LLC · Via GlobeNewswire · January 5, 2026
BALA CYNWYD, Pa., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · January 5, 2026
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of FONAR Corporation (NasdaqCM: FONR) to affiliates of Chief Executive Officer Timothy Damadian and certain executives and directors of the company. Under the terms of the proposed transaction, shareholders of FONAR will receive $19.00 per share of the Company's common stock, $19.00 per share of the Company's Class B common stock, $6.34 per share of the Company's Class C common stock. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
By Kahn Swick & Foti, LLC · Via Business Wire · December 30, 2025
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of FONAR Corporation (NASDAQ: FONR) to affiliates of Chief Executive Officer Timothy Damadian and certain executives and directors of the company for $19.00 per share for FONAR’s Class B common stock, and $6.34 per share for FONAR’s Class C common stock, is fair to FONAR shareholders.
By Halper Sadeh LLC · Via Business Wire · December 30, 2025
Melville, New York--(Newsfile Corp. - December 29, 2025) - FONAR Corporation (NASDAQ: FONR) ("FONAR" or the "Company"), The Inventor of...
Via Newsfile · December 29, 2025
Cash and cash equivalents decreased 4% to $54.3 million at September 30, 2025 as compared to the fiscal year-ended June...
Via Newsfile · November 10, 2025